Idelalisib reduces regulatory T cells and activates T helper 17 cell differentiation in relapsed refractory patients with chronic lymphocytic leukaemia is a research paper published in British Journal of Haematology (2022). On theSindex it has a DataRank of 0. It has been cited 15 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: NIH RO1 CA 213442
National Institutes of Health
Grant: NIH U01AI138318
National Institutes of Health
Grant: P30AR069625
National Institutes of Health
Grant: P30AR070253
NCI NIH HHS
Grant: R01 CA213442
NIAID NIH HHS
Grant: U01 AI138318
National Institutes of Health
Grant: 1R01CA213442-01A1
Unlocking the Potential of PI3K Inhibition in CLL
National Institutes of Health
Grant: 5P30AR069625-02
Human Skin Disease Resource-based Center
National Institutes of Health
Grant: 5U01AI138318-05
Therapy of acute radiation syndrome and its complications by mesenchymal stromal cells conditioned with Toll-like receptor 9 agonists
National Institutes of Health
Grant: 5P30AR070253-04
Joint Biology Consortium Resource-based Center
Gilead Sciences
National Comprehensive Cancer Network
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals